Kestra Medical Technologies, Ltd. (KMTS) stock
KMTSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends April 30
$25.10−1.53 (-5.75%)
Close on Nov 20, 2026Market cap $1.50BP/E –Yield –
Kestra Medical Technologies free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Kestra Medical Technologies's free cash flow for the twelve months ending Jul 31, 2026 was -$122.79M. For fiscal 2026 it was -$116.60M.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Apr 30, 2026 | -$116.60M | – |
| FY2025 | Apr 30, 2025 | -$100.54M | – |
| FY2024 | Apr 30, 2024 | -$84.46M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jul 31, 2026 | -$40.63M | – |
| Q4 FY2026CQ1 2026 | Apr 30, 2026 | -$28.38M | – |
| Q3 FY2026CQ4 2025 | Jan 31, 2026 | -$28.16M | – |
| Q2 FY2026CQ3 2025 | Oct 31, 2025 | -$25.61M | – |
| Q1 FY2026CQ2 2025 | Jul 31, 2025 | -$34.44M | – |
| Q4 FY2025CQ1 2025 | Apr 30, 2025 | -$31.45M | – |
| Q3 FY2025CQ4 2024 | Jan 31, 2025 | -$22.06M | – |
| Q2 FY2025CQ3 2024 | Oct 31, 2024 | -$22.50M | – |
| Q1 FY2025CQ2 2024 | Jul 31, 2024 | -$24.54M | – |
See a number that looks wrong?